- recruitingPHASE2
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
This study looks at whether people with myeloma can safely give themselves their bortezomib chemotherapy injections at home, or have a caregiver do it. This could make treatment easier by reducing hospital visits.
Canada - recruitingNA
Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients
This study looks at how special 'smart' weighing scales can help doctors keep an eye on patients with certain blood cancers like lymphoma and myeloma. Patients will use the scales daily at home, and the medical team will check the readings remotely to spot any changes early.
France - active not recruitingNA
Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
This study is testing a new, easier way to give a drug called isatuximab (currently given through a drip) for people newly diagnosed with multiple myeloma who can't have a stem cell transplant. It aims to see if giving it as an injection under the skin works as well and is as safe.
France